Researchers present sensor prototype that can rapidly, precisely, and cost-effectively measure molecular signals for cancer
The CRISPR/Cas technology can do more than alter genes. A research team at the University of Freiburg is using what are known as gene scissors – which scientists can use to edit genetic material – in order to better diagnose diseases such as cancer. In a study, the researchers introduce a microfluidic chip which recognizes small fragments of RNA, indicating a specific type of cancer more rapidly and precisely than the techniques available up to now. The results are recently published in the scientific journal “Advanced Materials.” They also tested the CRISPR biosensor on blood samples taken from four children who had been diagnosed with brain tumors. “Our electrochemical biosensor is five to ten times more sensitive than other applications which use CRISPR/Cas for RNA analysis,” explains Freiburg microsystems engineer Dr. Can Dincer. He is leading the research team together with biologist Prof. Dr. Wilfried Weber, of the University of Freiburg. “We’re doing pioneering work in Germany and Europe for this new application of gene scissors,” Dincer emphasizes.
Short molecules known as microRNA (miRNA) are coded in the genome, but unlike other RNA sequences, they are not translated into proteins. In some diseases, such as cancer or the neurodegenerative disease, Alzheimer’s, increased levels of miRNA can be detected in the blood. Doctors are already using miRNAs as a biomarker for certain types of cancer. Only the detection of a multitude of such signaling molecules allows an appropriate diagnosis. The researchers are now working on a version of the biosensor that recognizes up to eight different RNA markers simultaneously.
The CRISPR biosensor works as follows: A drop of serum is mixed with reaction solution and dropped onto the sensor. If it contains the target RNA, this molecule binds with a protein complex in the solution and activates the gene scissors – in a way similar to a key opening a door lock. Thus activated, the CRISPR protein cuts off, or cleaves, the reporter RNAs that are attached to signaling molecules, generating an electrical current. The cleavage results in a reduction of the current signals which can be measured electrochemically and indicates if the miRNA that is being sought is present in the sample. “What’s special about our system is that it works without the replication of miRNA, because in that case, specialized devices and chemicals would be required. That makes our system low-cost and considerably faster than other techniques or methods,” explains Dincer. He is working on new sensor technologies at the Freiburg Center for Interactive Materials and Bioinspired Technologies (FIT) and together with Prof. Dr. Gerald Urban at the Department of Microsystems Engineering (IMTEK).
Weber, a professor of synthetic biology at the cluster of excellence CIBSS – the Centre for Integrative Biological Signalling Studies of the University of Freiburg – emphasizes how important the interdisciplinary environment at CIBSS is for such a development: “The biologists at Freiburg work together on these technologies with their colleagues from the engineering and materials sciences. That opens new, exciting routes to solutions.” The researchers are aiming to further develop the system in about five to ten years to become the first rapid test for diseases with established microRNA markers that can be used right at the doctor’s office. “The laboratory equipment must nevertheless become easier to handle,” says Weber.
Learn more: Using Gene Scissors to Detect Diseases
The Latest Google Headlines on:
The Latest Bing News on:
- Rethinking cancer detectionon October 7, 2020 at 7:19 am
The survival statistics clearly reflect this – for example, almost nine in 10 people diagnosed with early stage bowel cancer survive their disease long term, but this drops below one in 10 of those ...
- Self-isolation on arrival at airports dramatically improves detection of disease importationon October 6, 2020 at 6:12 pm
Researchers from Public Health England have conducted a study showing that screening and quarantining travelers on arrival at airports significantly reduces the risk of disease importation during ...
- Vital rethinking in cancer early detection needed to save liveson October 6, 2020 at 6:18 am
Earlier detection of cancer offers arguably the single biggest opportunity to save lives from the disease, but there are many challenges of seeing this a reality for patients in the NHS, according to ...
- SIUE's Klingensmith Expands Heart Disease Research Under NIH Granton October 6, 2020 at 1:00 am
PRNewswire-PRWeb/ -- In support of his focus on the non-invasive assessment and possible detection of underlying coronary artery disease, ...
- Innovation could improve detection of COVID-19 infectionson October 5, 2020 at 9:33 am
A multidisciplinary research team at the National Institute of Standards and Technology (NIST) has developed a way to increase the sensitivity of the primary test used to detect the SARS-CoV-2 virus, ...
- Medieval Jerusalem latrine may hold secrets of modern-era gut diseaseson October 5, 2020 at 7:48 am
The Jerusalem latrine was found in the Christian Quarter of the Old City, close to the Church of the Holy Sepulchre in 1996 during excavations of a cesspool in the courtyard of a Spanish school.
- Cancer charity calls for significant investment to diagnose disease earlieron October 5, 2020 at 7:08 am
Earlier detection of cancer is the single biggest opportunity to save lives from the disease, but there are many challenges in making this a reality for patients in the NHS, a report from Cancer ...
- RetiSpec Announces Partnership With Gentex To Commercialize Alzheimer's Disease Detection Technologyon October 5, 2020 at 5:26 am
RetiSpec Inc. announced today that it is partnering with Gentex Corporation (NASDAQ: GNTX) to engineer, manufacture and commercialize technology for the early detection of Alzheimer's disease.
- Rapid detection of SARS-CoV-2 with portable CRISPR-based mobile phone diagnostic teston October 4, 2020 at 6:11 pm
A large group of researchers from the United States reported developing an amplification-free CRISPR-based mobile phone assay for direct detection of the severe acute respiratory syndrome coronavirus ...
- Worldwide Infectious Disease Point-of-Care Testing Industry to 2024 - Impact of the COVID-19 Pandemicon October 2, 2020 at 9:44 am
Based Solutions Spur the Global Infectious Disease Point-of-Care Testing Market, Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.
The Latest Google Headlines on:
The Latest Bing News on:
- Gene Editing Market Size Worth USD 15.79 Billion By 2027 | CAGR of 17.2%: Emergen Researchon September 29, 2020 at 8:04 am
Moreover, CRISPR is simple to use ... Microscopy, Light Therapy, Biosensors) and By End User (Medical Diagnostics, Medical Therapeutics, Test Components) Forecasts to 2027 Cancer Tumor Profiling ...
- UConn Researcher Developing ‘Blood-to-Answer’ Method for Early HIV Detectionon September 9, 2020 at 4:59 pm
Liu and his team will develop a highly sensitive, specific clustered regularly interspaced short palindromic repeats (CRISPR) biosensing technology ... His research interests include microfluidic ...
- Manifold roles of β-arrestins in GPCR signaling elucidated with siRNA and CRISPR/Cas9on September 9, 2020 at 4:59 pm
Studies based on CRISPR/Cas9-generated cell lines suggested that β-arrestins are dispensable for ERK1/2 activation. Luttrell et al. compared the effects of siRNA-mediated and CRISPR/Cas9-mediated ...
- Biotechnology could change the cattle industry. Will it succeed?on September 5, 2020 at 7:38 pm
Crispr-Cas9 is often celebrated for its potential to alter the blueprint of life, but that enormous promise can become a liability in the hands of rogue and unscrupulous researchers, tempting ...
- Programmable low-cost DNA-based platform for viral RNA detectionon August 21, 2020 at 1:29 pm
Among these are methods that adopt nanoparticles (14), graphene-based biosensors (15), and CRISPR-based methods (16, 17), to name a few. Many of these proposed strategies, although based on ...
- On Demand Webinarson January 29, 2020 at 2:59 pm
Sponsor: Domain TherapeuticsIn this GEN webinar, sponsored by Domain Therapeutics, we will discuss how the use of enhanced bystander bioluminescence energy transfer (ebBRET) biosensors and tag ...
- Full Memberson July 23, 2018 at 8:11 am
Research areas: Adolescent Health, Childhood Disorders, Stem Cells, Alzheimer’s Disease, Bioinformatics, Genetic, CRISPR, Omics I am a pianist ... Our lab has developed a unique label-free biosensor ...
- Scientists Edit Thousands of Genes at Once With Upgraded CRISPRon April 12, 2018 at 10:19 am
In the end, CRISPR may be used for far more than DNA editing—it could be a multi-functional tool that also works as a biosensor, a medical detective, and an invaluable instrument for basic research.
- Core B: Engineered Modelson February 19, 2016 at 8:40 pm
elegans and expand services to include CRISPR engineered mutations in zebrafish and mouse ... Aim 2: To Establish In Vivo Biosensors to Study Signaling Pathways Involved in HRFD Ciliopathies. To ...
- Vincent Martin, PhDon April 30, 2015 at 8:46 am
Seamless and site-directed mutagenesis of the Saccharomycescerevisae genome using CRISPR-Cas9. Journal of Biological Engineering ... 2015. An enzyme-coupled biosensor enables (S)-reticuline production ...